"That would bring the cost to $2,340 for foreign and U.S. Medicare patients and $3,120 for U.S. patients with private health coverage."
"preliminary results from a study that showed Covid-19 patients who took the drug usually recovered after 11 days, four days faster than those who didn’t take it."
They did not mention anyone not recovering either with or without the treatment. Assuming all would survive COVID-19 (which we know is not the case), who in their right mind would pay between $2,340 to $3,120 to reduce the recovery time by only 26%?